Lara Sosic
Zurich, ZH, Switzerland
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 9 publications
Microcrystalline tyrosine as a novel depot-forming agent in venom immunotherapy: a pre-clinical evaluation in bee-venom allergic mice.
Journal: Frontiers in allergy
Published: March 27, 2026
Efficacy and Safety of Intralymphatic Immunotherapy With Grass Allergoid and Microcrystalline Tyrosine: A Double-Blind Randomised Placebo-Controlled Trial.
Journal: Allergy
Published: March 13, 2026
Patient-Derived IgG Epitope Mapping of Bet v 1 Reveals Hypoallergenic Peptide Candidates for Safe and Next-Generation Allergen Immunotherapy.
Journal: Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology
Published: May 22, 2025
How to hit the allergy target: A critical appraisal of intralymphatic immunotherapy with practical recommendations on ultrasound-guided injections.
Journal: Allergy
Published: February 02, 2024
Allergen immunotherapy: progress and future outlook.
Journal: Expert review of clinical immunology
Published: April 30, 2023
Quality of life in allergic rhinitis patients treated with intralymphatic immunotherapy (ILIT): A 19-year follow-up.
Journal: The journal of allergy and clinical immunology. Global
Published: March 31, 2022
Intralymphatic Immunotherapy (ILIT) With Bee Venom Allergens: A Clinical Proof-of-Concept Study and the Very First ILIT in Humans.
Journal: Frontiers in allergy
Published: December 09, 2021
Kinetics and persistence of anti-SARS-CoV-2 neutralisation and antibodies after BNT162b2 vaccination in a Swiss cohort.
Journal: Immunity, inflammation and disease
Published: October 19, 2021
Showing 1-9 of 9
Last Updated: 09/26/2026